TIDMMKA
Mkango Resources Limited
01 June 2020
MKANGO RESOURCES LTD.
550 Burrard Street
Suite 2900
Vancouver
BC V6C 0A3
Canada
MKANGO DONATES STATE OF THE ART ANAESTHETIC MACHINE TO THE MERCY
JAMES CENTRE AT THE QUEEN ELIZABETH CENTRAL HOSPITAL IN BLANTYRE
MALAWI TO ASSIST IN COMBATING
COVID 19
London / Vancouver: June 1, 2020 - Mkango Resources Ltd.
(AIM/TSX-V: MKA) (the "Company" or "Mkango") is pleased to announce
the donation of a new state of the art Mindray WATO EX-20
anaesthetic machine to the Mercy James Centre at the Queen
Elizabeth Central Hospital in Blantyre, Malawi.
The new anaesthetic machine, will help enable the Queen
Elizabeth Central Hospital to set up a new operating theatre for
emergency operations, specifically for patients who are suspected
of having the COVID 19 virus.
Mr Alexander Lemon, President of Mkango Resources stated:
" We are delighted to donate this anaesthetic machine to the
Mercy James Centre at the Queen Elizabeth Central Hospital to help
fight the growing pandemic of COVID 19 in Malawi. We hope that it
will potentially help save many lives in the coming years. Mkango
is committed to supporting the country in which it operates, as it
moves towards the sustainable development of the Songwe Hill rare
earths project in Malawi. "
Professor Eric Borgstein, Consultant Pediatric Surgeon at the
Queen Elizabeth Central Hospital and Professor of Surgery at the
University of Malawi College of Medicine, stated:
"Surgical emergencies cannot wait. While the hospital is
struggling to respond to the new demands of the Coronavirus
epidemic, the provision of care for patients with acute surgical
conditions must go on! It is gratifying to see Mkango Resources
making such a timely donation, which will benefit all our various
patients, not only now but for years to come. This new anaesthetic
machine will enable us to set up a separate operating theatre for
patients who may be COVID infected; thereby keeping the existing
theatres free for the many daily surgical emergencies. A great
example of appropriate, effective and useful assistance to our
hospital."
Dr Singatiya Stella Chikumbanje, Consultant Anaesthetist at
Queen Elizabeth Central Hospital, stated:
"We are grateful for the donation of this anaesthetic machine.
The arrival of the anaesthetic machine is very timely, as it will
help in our provision of safe anaesthesia for our patients during
the COVID period and beyond. Hopefully other companies will emulate
Mkango's generosity and allow us to provide improved care to all
our patients."
The Mindray WATO EX-20 anaesthetic machine was purchased from
Worldwide Pharmaceutical Distributors who are agents and
distributors for Mindray in Malawi.
About The Mercy James Centre for Paediatric Surgery and
Intensive Care (MJC) and Queen Elizabeth Hospital
The MJC is located in the grounds of the 1000 bed Queen
Elizabeth Central Hospital, the largest public and teaching
hospital in Malawi. The MJC was developed by Raising Malawi, a
non-government organisation founded by Madonna, in collaboration
with the Malawian health ministry.
About Mkango
M kang o 's pri mary busin e ss is explorat i on for rare earth
ele me n ts and associat ed min erals in the Re public of Malawi, a
country whose hospitable people have earned it a reputation as "the
warm heart of Africa". The Company holds interests in four e
xclusive prosp ecting lice n s es in Malawi: the Phalombe licence,
the Thambani licence, the Chimimbe Hill licence and the Mchinji
licence.
The main exploration target in the 51% held Phalombe licence is
the Songwe Hill rare earths deposit. This features
carbonatite-hosted rare earth mineralisation and was subject to
previous exploration in the late 1980s. Mkango completed an updated
Pre-Feasibility Study for the project in November 2015 and a
Feasibility Study is currently underway, the initial phases of
which included a 10,900 metre drilling programme and an updated
mineral resource estimate, announced in February 2019. In March
2019, the Company announced receipt of a GBP7 million (C$12.3
million) investment from Talaxis to fund completion of the
Feasibility Study. Following completion of the Feasibility Study,
Talaxis has an option to acquire a further 26% interest in Songwe
by arranging financing for project development including funding
the equity component thereof.
The main exploration targets in Mkango's remaining three 100%
held licences are, in the Thambani licence, uranium, niobium,
tantalum and zircon, in the Chimimbe Hill licence, nickel and
cobalt, and in the Mchinji licence, rutile, nickel, cobalt, base
metals and graphite.
Mkango also holds a 75.5% interest in Maginito with the balance
owned by Talaxis. Maginito is focused on downstream opportunities
relating to the rare earths supply chain, in particular, recycling
and other innovative technologies for the production of neodymium
alloy powders and magnets used in electric vehicles, wind turbines
and other industries geared to decarbonisation of the economy.
For further information on Mkango, please contact:
Mkango Resources Limited
William Dawes Alexander Lemon
Chief Executive Officer President
will@mkango.ca alex@mkango.ca
Canada: +1 403 444 5979
www.mkango.ca
@MkangoResources
Blytheweigh
Financial Public Relations
Tim Blythe, Camilla Horsfall
UK: +44 207 138 3204
SP Angel Corporate Finance LLP
Nominated Adviser and Joint Broker
Jeff Keating, Caroline Rowe
UK: +44 20 3470 0470
Alternative Resource Capital
Joint Broker
Alex Wood, Rob Collins
UK: +44 20 7186 9004; +44 20 7186 9001
The TSX Venture Exchange has neither approved nor disapproved
the contents of this press release. Neither the TSX Venture
Exchange nor its Regulation Services Provider (as that term is
defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
This press release does not constitute an offer to sell or a
solicitation of an offer to buy any equity or other securities of
the Company in the United States. The securities of the Company
will not be registered under the United States Securities Act of
1933, as amended (the "U.S. Securities Act") and may not be offered
or sold within the United States to, or for the account or benefit
of, U.S. persons except in certain transactions exempt from the
registration requirements of the U.S. Securities Act.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRAEKLFLBELFBBZ
(END) Dow Jones Newswires
June 01, 2020 02:00 ET (06:00 GMT)
Mkango Resources (LSE:MKA)
Historical Stock Chart
From Apr 2024 to May 2024
Mkango Resources (LSE:MKA)
Historical Stock Chart
From May 2023 to May 2024